Simeprevir, Sofosbuvir, and the Limitations of the COSMOS
Aug 4, 2014
August 4, 2014
August 4, 2014
Topics
SIM-SOF is a great advance in hepatitis C treatment, but treatment failures will happen, says Dr. Paul Sax in HIV and ID Observations.
The approval of simeprevir and sofosbuvir has made curing hepatitis C a whole lot easier, but — as demonstrated in the recent COSMOS study — the treatments aren't perfect. Read more in HIV and ID Observations.